4//SEC Filing
Romano Sarah 4
Accession 0001140361-22-007549
CIK 0001604191other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:02 PM ET
Size
5.1 KB
Accession
0001140361-22-007549
Insider Transaction Report
Form 4
Romano Sarah
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2022-03-01+150,000→ 150,000 totalExercise: $1.18Exp: 2032-03-01→ Common stock, par value $0.0001 per share (150,000 underlying)
Footnotes (1)
- [F1]The stock option vests in three equal annual installments commencing on March 1, 2023.
Documents
Issuer
First Wave BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001697536
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:02 PM ET
- Size
- 5.1 KB